gastro-jРоссийский журнал гастроэнтерологии, гепатологии, колопроктологииRussian Journal of Gastroenterology, Hepatology, Coloproctology1382-43762658-6673«Gastro» LLC10.22416/1382-4376-2020-30-3-7gastro-j-468Research ArticleРЕДАКЦИОННАЯEDITORIALНовая коронавирусная инфекция (COVID-19) и система органов пищеваренияNew Coronavirus Infection (COVID-19) and Digestive Systemhttps://orcid.org/0000-0002-6815-6015ИвашкинВ. Т.IvashkinV. T.

Ивашкин Владимир Трофимович — доктор медицинских наук, профессор, академик РАН, заведующий кафедрой пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета 

119435, г. Москва, ул. Погодинская, д 1, стр. 1.

Vladimir T. Ivashkin — Dr. Sci. (Med.), RAS Academician, Prof., Departament Head, Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

kont07@yandex.ruhttps://orcid.org/0000-0002-1395-9566ШептулинА. А.SheptulinA. A.

Шептулин Аркадий Александрович — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета 

119435, г. Москва, ул. Погодинская, д.1, стр.1.

Arkady A. Sheptulin — Dr. Sci. (Med.), Prof., Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

arkalshep@gmail.comhttps://orcid.org/0000-0002-6701-789XЗольниковаО. Ю.ZolnikovaO. Yu.

Зольникова Оксана Юрьевна — кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета

119435, г.Москва, ул.Погодинская, д.1, стр.1.

Oxana Yu. Zolnikova — Cand. Sci. (Med.), Associate Prof., Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

ks.med@mail.ruhttps://orcid.org/0000-0002-4617-2292ОхлобыстинА. В.OkhlobystinA. V.

Охлобыстин Алексей Викторович — кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета

119435, г.Москва, ул.Погодинская, д.1, стр.1

Alexey V. Okhlobystin — Cand. Sci. (Med.), Associate Prof., Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

okhlobystin@mail.ruПолуэктоваЕ. А.PoluektovaE. A.

Полуэктова Елена Александровна — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета

119435, г.Москва, ул.Погодинская, д.1, стр.1

Elena A. Poluektova — Dr. Sci. (Med.), Prof., Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

polouektova@rambler.ruhttps://orcid.org/0000-0003-3362-2968ТрухмановА. С.TrukhmanovA. S.

Трухманов Александр Сергеевич — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета

119435, г. Москва, ул. Погодинская, д.1, стр.1.

Alexander S. Trukhmanov — Dr. Sci. (Med.), Prof., Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

alexander.trukhmanov@gmail.comhttps://orcid.org/0000-0002-6819-0889ШироковаЕ. Н.ShirokovaE. N.

Широкова Елена Николаевна — доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета

119435, г. Москва, ул. Погодинская, д.1, стр.1.

Elena N. Shirokova — Dr. Sci. (Med.), Prof., Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

eshirokova@yandex.ruhttps://orcid.org/0000-0002-0605-8057ГоникМ. И.GonikM. I.

Гоник Максим Игоревич — клинический ординатор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета

119435, г.Москва, ул.Погодинская, д.1, стр.1

Maxim I. Gonik — Clinical Resident, Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

maximgonik@gmail.comТрофимовскаяН. И.TrofimivskayaN. I.

Трофимовская Наталья Игоревна — клинический ординатор кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии лечебного факультета

119435, г.Москва, ул.Погодинская, д.1, стр.1

Natalia I. Trofimivskaya — Clinical Resident, Departament of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology

119435, Moscow, Pogodinskaya str., 1, building 1.

n.trofimovskaya@mail.ruФГАОУ ВО «Первый Московский государственный университет им. И.М. Сеченова» (Сеченовский университет) Министерства здравоохранения Российской ФедерацииРоссияSechenov First Moscow State Medical University (Sechenov University)Russian FederationФГАОУ ВО «Первый Московский государственный университет им. И.М.Сеченова» (Сеченовский университет) Министерства здравоохранения Российской ФедерацииРоссияSechenov First Moscow State Medical University (Sechenov University)Russian Federation202017042020303713Copyright © Ивашкин В.Т., Шептулин А.А., Зольникова О.Ю., Охлобыстин А.В., Полуэктова Е.А., Трухманов А.С., Широкова Е.Н., Гоник М.И., Трофимовская Н.И., 20202020Ивашкин В.Т., Шептулин А.А., Зольникова О.Ю., Охлобыстин А.В., Полуэктова Е.А., Трухманов А.С., Широкова Е.Н., Гоник М.И., Трофимовская Н.И.Ivashkin V.T., Sheptulin A.A., Zolnikova O.Y., Okhlobystin A.V., Poluektova E.A., Trukhmanov A.S., Shirokova E.N., Gonik M.I., Trofimivskaya N.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gastro-j.ru/jour/article/view/468

Цель настоящего обзора заключается в изложении современных данных о поражении органов пищеварительной системы при новой коронавирусной инфекции (COVID-19).

Основные положения

Основные положения. Помимо признаков поражения дыхательной системы при COVID-19 наблюдаются желудочно-кишечные симптомы (тошнота, рвота, диарея), которые могут предшествовать появлению респираторных симптомов и выходить на первый план в клинической картине заболевания. Больные с хроническими воспалительными заболеваниями кишечника, получающие иммуносупрессивную терапию, входят в группу повышенного риска развития COVID-19. При новой коронавирусной инфекции могут отмечаться признаки поражения печени с повышением активности трансаминаз.

Заключение

Заключение. Вопросы о связи поражений органов пищеварения с COVID-19 остаются недостаточно изученными и требуют дальнейших исследований.

Aim

Aim. The study reviews current evidence on digestive system lesions provoked by the new COVID-19 coronavirus infection.

Key points

Key points. Alongside the destructive impact on respiratory system, COVID-19 manifests itself in gastrointestinal symptoms (nausea, vomiting, diarrhoea) that may precede respiratory signs and prevail in the clinical picture of infection. Patients with chronic inflammatory bowel diseases receiving immunosuppressive therapy are at elevated risk of severe COVID-19 progression. The new coronavirus infection may induce liver damage with increased transaminase activity.

Conclusion

Conclusion. Association of digestive system lesions with COVID-19 remains understudied and requires further research.

новая коронавирусная инфекцияжелудочно-кишечные симптомывоспалительные заболевания кишечникапеченьnew coronavirus infectiongastrointestinal symptomsinflammatory bowel diseasesliverReferencesВременные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». URL: rosminzdrav.ru/ministry/med_covid19.Interim methodological guidelines «Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)» (In Russ.) URL: rosminzdrav.ru/ministry/med_covid19.Gu J., Han, B., Wang J. COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology. 2020;158(6):1518–19. DOI: 10.1053/j.gastro.2020.02.054.Gu J., Han, B., Wang J. COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology. 2020;158(6):1518–19. DOI: 10.1053/j.gastro.2020.02.054.Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Mar 5;382(10):929–36. DOI: 10.1056/NEJMoa2001191Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Mar 5;382(10):929–36. DOI: 10.1056/NEJMoa2001191Xiao F., Tang M., Zheng X. Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020; 158(6):1831–33. DOI:10.1053/j.gastro.2020.02.055Xiao F., Tang M., Zheng X. Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020; 158(6):1831–33. DOI:10.1053/j.gastro.2020.02.055Zhang W., Du R.H., Li B., Xu D., Wang J., Li Z., Lin J. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020;9(1):386–9. DOI:10.1080/22221751.2020.1729071Zhang W., Du R.H., Li B., Xu D., Wang J., Li Z., Lin J. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020;9(1):386–9. DOI:10.1080/22221751.2020.1729071Tang A., Tong Z.D., Wang H.L., Dai Y.X., Li K.F., Liu J.N., et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020;26(6):1337–39. DOI: 10.3201/eid2606.200301.Tang A., Tong Z.D., Wang H.L., Dai Y.X., Li K.F., Liu J.N., et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020;26(6):1337–39. DOI: 10.3201/eid2606.200301.Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.J., Loh J., et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488–94. DOI:10.1001/jama.2020.3204Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.J., Loh J., et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488–94. DOI:10.1001/jama.2020.3204Chan K.H., Poon L.L., Cheng V.C., Guan Y., Hung I.F., Kong J., et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004;10(2):294–9. DOI:10.3201/eid1002.030610Chan K.H., Poon L.L., Cheng V.C., Guan Y., Hung I.F., Kong J., et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004;10(2):294–9. DOI:10.3201/eid1002.030610Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020;5(5):434–35. DOI: 10.1016/S2468-1253(20)30083-2Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020;5(5):434–35. DOI: 10.1016/S2468-1253(20)30083-2To K.K.W., Tsang O.T.Y., Yip C.C.Y., Chan K.H., Wu T.C., Chan J.V.C., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020; 12:149. DOI: 10.1093/cid/ciaa149To K.K.W., Tsang O.T.Y., Yip C.C.Y., Chan K.H., Wu T.C., Chan J.V.C., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020; 12:149. DOI: 10.1093/cid/ciaa149Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224):565–74. DOI: 1016/S0140-6736(20)30251-8Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224):565–74. DOI: 1016/S0140-6736(20)30251-8Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798):270–273. DOI: 10.1038/s41586-020-2012-7Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798):270–273. DOI: 10.1038/s41586-020-2012-7Liang W., Feng Z., Rao S., Xiao O., Xue X., Lin Z., et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020;69(6):1141–43. DOI: 10.1136/gutjnl-2020-320832Liang W., Feng Z., Rao S., Xiao O., Xue X., Lin Z., et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 2020;69(6):1141–43. DOI: 10.1136/gutjnl-2020-320832Guan W.-J., Ni Z.-Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. DOI:10.1056/NEJMoa2002032Guan W.-J., Ni Z.-Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. DOI:10.1056/NEJMoa2002032Pan L., Mu M., Ren H. G., Yang P., Sun Y. Wang R., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, 2020;115(5):766–73. DOI: 10.14309/ajg.0000000000000620Pan L., Mu M., Ren H. G., Yang P., Sun Y. Wang R., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, 2020;115(5):766–73. DOI: 10.14309/ajg.0000000000000620Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–69. DOI:10.1001/jama.2020.1585Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–69. DOI:10.1001/jama.2020.1585Lin L., Jiang X., Zhang Z., Huang S., Zhang Z., Fang Z., et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020; 69(6):997–1001 DOI: 10.1136/gutjnl-2020-321013Lin L., Jiang X., Zhang Z., Huang S., Zhang Z., Fang Z., et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020; 69(6):997–1001 DOI: 10.1136/gutjnl-2020-321013Song Y., Liu P., Shi X.L., Chu J.L., Zhang J., Xia J., et al. SARS-CoV-2 induced diarrhea as onset symptom in patient with COVID-19. Gut. 2020;69(6):1143–44. DOI: 10.1136/gutjnl-2020-320891Song Y., Liu P., Shi X.L., Chu J.L., Zhang J., Xia J., et al. SARS-CoV-2 induced diarrhea as onset symptom in patient with COVID-19. Gut. 2020;69(6):1143–44. DOI: 10.1136/gutjnl-2020-320891Liu K., Fang Y.-Y., Deng Y., Liu W., Wang M.-F., Ma J.-P.,et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J 2020;133(9):1025–31. DOI: 10.1097/CM9.0000000000000744Liu K., Fang Y.-Y., Deng Y., Liu W., Wang M.-F., Ma J.-P.,et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J 2020;133(9):1025–31. DOI: 10.1097/CM9.0000000000000744Ungaro R.C., Sullivan T., Colombel J.-F., Patel G. What should gastroenterologists and patients know about COVID-19? Clin Gastroenterol Hepatol. 2020;18(7):1409–11. DOI: 10.1016/j.cgh2020.03.02Ungaro R.C., Sullivan T., Colombel J.-F., Patel G. What should gastroenterologists and patients know about COVID-19? Clin Gastroenterol Hepatol. 2020;18(7):1409–11. DOI: 10.1016/j.cgh2020.03.02Jin X., Lian J.-S., Hu J.-H., Gao J., Zheng L., Zhang Y.-M., et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002–09. DOI:10.1136/gutjnl-2020-320926Jin X., Lian J.-S., Hu J.-H., Gao J., Zheng L., Zhang Y.-M., et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002–09. DOI:10.1136/gutjnl-2020-320926Hormati A, Shahhamzeh A, Afifian M, Khodadust F, Ahmadpour S. Can COVID-19 present unusual GI symptoms? J Microbiol Immunol Infect. 2020. DOI:10.1016/j.jmii.2020.03.020Hormati A, Shahhamzeh A, Afifian M, Khodadust F, Ahmadpour S. Can COVID-19 present unusual GI symptoms? J Microbiol Immunol Infect. 2020. DOI:10.1016/j.jmii.2020.03.020Mazza S., Sorce A., Peyvandy F., Vecchi M., Caprioli F. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut. 2020;69(6):1148–49. DOI: 10.1136/gutjnl-2020-321183Mazza S., Sorce A., Peyvandy F., Vecchi M., Caprioli F. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut. 2020;69(6):1148–49. DOI: 10.1136/gutjnl-2020-321183Mao, R., Liang, J., Shen J., Ghosh S., Zhu L.-R., Yang H., et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5(5):425–27. DOI: 10.1016/S2468-1253(20)30076-5Mao, R., Liang, J., Shen J., Ghosh S., Zhu L.-R., Yang H., et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5(5):425–27. DOI: 10.1016/S2468-1253(20)30076-5Rubin D.T., Abrey M.T., Rai V., Siegel C.A. International Organization for the Study of Inflammatory Bowel Disease. Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting. Gastroenterology. 2020; S0016-5085(20)30465-0. DOI: 10.1053/j.gastro.2020.04.002Rubin D.T., Abrey M.T., Rai V., Siegel C.A. International Organization for the Study of Inflammatory Bowel Disease. Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting. Gastroenterology. 2020; S0016-5085(20)30465-0. DOI: 10.1053/j.gastro.2020.04.002Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A., et al. Specific ACE2 Expression in cholangiocytes COVID-19 may cause liver damage after 2019-nCoV infection. bioRxiv. 2020; DOI:10.1101/2020.02.03.931766Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A., et al. Specific ACE2 Expression in cholangiocytes COVID-19 may cause liver damage after 2019-nCoV infection. bioRxiv. 2020; DOI:10.1101/2020.02.03.931766Xu J., Helfand B. Genetic risk score linked with younger age diagnosis of prostate cancer. Oncology Times. 2020;42(6):8,36. DOI:10.1097/01.cot.0000658832.18056.12Xu J., Helfand B. Genetic risk score linked with younger age diagnosis of prostate cancer. Oncology Times. 2020;42(6):8,36. DOI:10.1097/01.cot.0000658832.18056.12Albillos A., Lario M., Álvarez-Mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. J Нepatol. 2014;61(6):1385–96. DOI:10.1016/j.jhep.2014.08.010Albillos A., Lario M., Álvarez-Mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. J Нepatol. 2014;61(6):1385–96. DOI:10.1016/j.jhep.2014.08.010Boettler T., Newsome P.N., Mondelli M.U., Matitic M., Cordeo E., Cornberg M., et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep. 2020;2(3):100113. DOI:10.1016/j.jhepr.2020.100113Boettler T., Newsome P.N., Mondelli M.U., Matitic M., Cordeo E., Cornberg M., et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep. 2020;2(3):100113. DOI:10.1016/j.jhepr.2020.100113Fan Z., Chen L., Li J., Tian C., Zhang Y., Huang S., Liu Z., Cheng J. Clinical Features of COVID-19-Related Liver Damage. 2020. Available at SSRN 3546077. DOI:10.2139/ssrn.3546077Fan Z., Chen L., Li J., Tian C., Zhang Y., Huang S., Liu Z., Cheng J. Clinical Features of COVID-19-Related Liver Damage. 2020. Available at SSRN 3546077. DOI:10.2139/ssrn.3546077Chen N., Zhou M., DongX., Qu J., Gong F., Han Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507–13. DOI:10.1016/S0140-6736(20)30211-7Chen N., Zhou M., DongX., Qu J., Gong F., Han Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507–13. DOI:10.1016/S0140-6736(20)30211-7Ong J., Young B.E., Ong S. COVID-19 in gastroenterology: a clinical perspective. Gut. 2020;69(6):1144–45. DOI: 10.1136/gutjnl-2020-321051.Ong J., Young B.E., Ong S. COVID-19 in gastroenterology: a clinical perspective. Gut. 2020;69(6):1144–45. DOI: 10.1136/gutjnl-2020-321051.Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., et al. Patholigical findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420–2. DOI: 10.1016/S2213-2600(20)30076-XXu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., et al. Patholigical findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420–2. DOI: 10.1016/S2213-2600(20)30076-XLi X., Geng M., Peng Y., Meng L., Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 2020;10(2):102–8. DOI: 10.1016/j.jpha.2020.03.001.Li X., Geng M., Peng Y., Meng L., Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 2020;10(2):102–8. DOI: 10.1016/j.jpha.2020.03.001.Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S, Manson J.J. COVID-19: consider cytokine storm syndromes and immunosupression. Lancet. 2020;395(10229):1033–34. DOI:10.1016/S0140-6736(20)30628-0.Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S, Manson J.J. COVID-19: consider cytokine storm syndromes and immunosupression. Lancet. 2020;395(10229):1033–34. DOI:10.1016/S0140-6736(20)30628-0.Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet.2020;395(10229):1054–62. DOI:10.1016/S0140-6736(20)30566-3.Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet.2020;395(10229):1054–62. DOI:10.1016/S0140-6736(20)30566-3.https://www.foodnavigator-asia.com/Article/2020/03/17/Fight-COVID-19-with-dairy-China-industry-associations-issue-consumption-guidelines-to-build-immuneresistance?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyrighthttps://www.foodnavigator-asia.com/Article/2020/03/17/Fight-COVID-19-with-dairy-China-industry-associations-issue-consumption-guidelines-to-build-immuneresistance?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyrightWHO. Coronavirus disease (COVID-19) advice for the public: Myth busters [Internet]. WHO: WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-bustersWHO. Coronavirus disease (COVID-19) advice for the public: Myth busters [Internet]. WHO: WHO; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-bustersBritish Dietetic Association. COVID-19 / Coronavirus — Advice for the General Public: «Can I boost my immune system through my diet?» 16 Mar 2020 [updated April 14 2020]. BDA: BDA; Available from https://www.bda.uk.com/resource/covid-19-corona-virus-advice-for-the-general public.htmlBritish Dietetic Association. COVID-19 / Coronavirus — Advice for the General Public: «Can I boost my immune system through my diet?» 16 Mar 2020 [updated April 14 2020]. BDA: BDA; Available from https://www.bda.uk.com/resource/covid-19-corona-virus-advice-for-the-general public.htmlWHO. Food and nutrition tips during self-quarantine [Internet]. WHO: WHO; 2020. Available from: http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov-technical-guidance/food-and-nutrition-tips-during-self-quarantineWHO. Food and nutrition tips during self-quarantine [Internet]. WHO: WHO; 2020. Available from: http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov-technical-guidance/food-and-nutrition-tips-during-self-quarantine

The authors declare that there are no conflicts of interest present.